Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anaphase promoting complex subunit 10 pseudogene 1 (ANAPC10P1)
- Target
- ANAPC10P1
- Molecular classification
- Other (Pseudogene)
01
Overview
ANAPC10P1 is a processed pseudogene derived from the protein-coding gene "anaphase promoting complex subunit 10" (ANAPC10). Processed pseudogenes arise by reverse transcription of parent gene mRNA and reintegration into the genome, typically lacking protein-coding function and introns. While some pseudogenes regulate their parent genes by acting as RNA decoys or sources of regulatory small RNAs, there is no experimental evidence for ANAPC10P1 having a distinct biological function, protein product, or role as a therapeutic target. It is best classified as a nonfunctional genomic element with possible, but unconfirmed, regulatory capabilities via non-coding RNA mechanisms. This target is not suitable for drug development or direct therapeutic research.
- Other names
- ANAPC10PENSG00000257512Processed pseudogene 1 of anaphase promoting complex subunit 10
02
Mechanism of action
None (No known drug mechanisms as it is not a protein target)
03
Biological functions
Possible regulation of parent gene expression via non-coding RNA mechanisms, siRNAs, or as miRNA decoy (general to pseudogenes; specific function for ANAPC10P1 not experimentally confirmed)
04
Disease associations
None established (Pseudogenes in general can act as regulatory elements in cancer and other diseases, but no disease association is directly documented for ANAPC10P1)
05
Safety considerations
None (Not a drug target)
Beyond the preview
Go deeper on Anaphase promoting complex subunit 10 pseudogene 1 (ANAPC10P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anaphase promoting complex subunit 10 pseudogene 1 (ANAPC10P1).